Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             580 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal white matter integrity in elderly patients with idiopathic normal-pressure hydrocephalus: A tract-based spatial statistics study Kang, Kyunghun
2016
22 S2 p. e160-
1 p.
artikel
2 A case of hemifacial spasm in young adult Gabrielyan, Inessa
2016
22 S2 p. e137-
1 p.
artikel
3 A case of premenstrual tremor Khachaturyan, Sofiya
2016
22 S2 p. e34-e35
nvt p.
artikel
4 A case series of coexisting Parkinson's disease and epilepsy Son, Andre
2016
22 S2 p. e64-
1 p.
artikel
5 A clinicoradiologic study of hypertrophic olivary degeneration Konno, Takuya
2016
22 S2 p. e141-
1 p.
artikel
6 A comparative study of oxidative stress markers between the tremor dominant and akinetic-rigid subtypes of patients with Parkinson's disease Naduthota, Rajini
2016
22 S2 p. e31-
1 p.
artikel
7 A comparison of deep brain stimulation and continuous intrajejunal levodopa infusion in advanced Parkinson’s disease: The INVEST study van Poppelen, Daniel
2016
22 S2 p. e105-
1 p.
artikel
8 A comparison study for the optimal stimulation site of high-frequency repetitive transcranial magnetic stimulation in Parkinson’s disease Yokoe, Masaru
2016
22 S2 p. e114-
1 p.
artikel
9 A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm Truong, Daniel
2016
22 S2 p. e138-
1 p.
artikel
10 Acute allergic reaction following injection of generic, government-provided, Botulinum toxin (GGP-BTA) for hemifacial spasm Teive, Helio
2016
22 S2 p. e138-e139
nvt p.
artikel
11 Acute parkinsonism as a predominant sign of neuroleptic malignant syndrome in a patient with schizophrenia Koprivnik, Petra
2016
22 S2 p. e125-
1 p.
artikel
12 Acute restless legs syndrome in a patient with Guillain-Barre syndrome Ozmenoglu, Mehmet
2016
22 S2 p. e132-e133
nvt p.
artikel
13 Adult neural progenitor cells auto transplantation in a non-human primate model of Parkinson’s disease: A pre-clinical study Cottet, Jerome
2016
22 S2 p. e114-e115
nvt p.
artikel
14 Affected side is a prognostic factor in typist's cramp Kang, Suk Yun
2016
22 S2 p. e136-
1 p.
artikel
15 Alertness as assessed by clinical testing and alpha reactivity does not correlate with executive function decline in Parkinson's disease (PD) Sturzenegger, Rolf
2016
22 S2 p. e164-e165
nvt p.
artikel
16 Alertness as assessed by clinical testing and alpha reactivity does not correlate with executive function decline in Parkinson's disease (PD) Sturzenegger, Rolf
2016
22 S2 p. e143-
1 p.
artikel
17 Alpha-synuclein immunohistochemistry studies of gastrointestinal tissue from patients with prodromal Parkinson's disease Stokholm, Morten Gersel
2016
22 S2 p. e46-e47
nvt p.
artikel
18 Alpha-synuclein mutations in Parkinson Disease in the Kazakh population Akanova, Assiya
2016
22 S2 p. e170-
1 p.
artikel
19 Alpha-synuclein mutations in Parkinson Disease in the Kazakh population. Akanova, Assiya
2016
22 S2 p. e144-e145
nvt p.
artikel
20 Alteration of striatal tetrahydrobiopterin in iron-induced unilateral model of Parkinson's disease Aryal, Bijay
2016
22 S2 p. e187-
1 p.
artikel
21 Alterations in the dynamic balance level in elderly with Parkinson's disease Méndez-Rial, Belia
2016
22 S2 p. e52-
1 p.
artikel
22 Altered functional topography of the striatum in resting state fMRI in Parkinson's disease Tan, Sun Nee
2016
22 S2 p. e81-e82
nvt p.
artikel
23 Altered functional topography of the striatum in resting state fMRI in Parkinson's disease Tan, Sun Nee
2016
22 S2 p. e156-
1 p.
artikel
24 Ameliorative effects of 1,3,4-thiadiazole derivatives on scopolamine induced cognitive deficits in mice Kulshreshtha, Akanksha
2016
22 S2 p. e146-
1 p.
artikel
25 Ameliorative effects of 1,3,4-thiadiazole derivatives on scopolamine induced cognitive deficits in mice Kulshreshtha, Akanksha
2016
22 S2 p. e178-
1 p.
artikel
26 A molecular and genetic basis study in POLG mutation of MtDNA in Parkinson patients in South Indian population Alagamuthu, Karthick Kumar
2016
22 S2 p. e170-e171
nvt p.
artikel
27 A multicenter epidemiological and clinical study on deep brain stimulation (DBS) for Parkinson's disease: The pilot study* Scelzo, Emma
2016
22 S2 p. e105-
1 p.
artikel
28 An alternative perspective on interpretation of the cardinal motor symptoms of Parkinson disease Vucolova, Ludmila
2016
22 S2 p. e5-
1 p.
artikel
29 An alternative perspective on interpretation of the cardinal motor symptoms of Parkinson's disease Vucolova, Ludmila
2016
22 S2 p. e49-
1 p.
artikel
30 An alternative perspective on interpretation of the secondary motor symptoms of Parkinson disease Vucolova, Ludmila
2016
22 S2 p. e4-e5
nvt p.
artikel
31 An alternative perspective on interpretation of the secondary motor symptoms of Parkinson's disease Vucolova, Ludmila
2016
22 S2 p. e48-e49
nvt p.
artikel
32 Analysis of GABA and serotonin levels concordance with vitamin D receptor gene (VDR) polymorphism in Late onset Alzheimer disease (LOAD) Ahammed Khan, Mustaqahamed Shafi
2016
22 S2 p. e175-e176
nvt p.
artikel
33 Analysis of the effectiveness of CEA and evaluation of factors affecting its long-term results Ataniyazov, Makhsudjan
2016
22 S2 p. e124-e125
nvt p.
artikel
34 Analysis of weight and BMI among patients with Huntington’s disease Szejko, Natalia
2016
22 S2 p. e133-
1 p.
artikel
35 Anatomical profile of cognitive impairment in MSA Fiorenzato, Eleonora
2016
22 S2 p. e118-
1 p.
artikel
36 An experimental study of transplantation of human amniotic epithelial cells in the corpus striatum of Parkinson's induced wistar albino rats Ravisankar, Periyasamy
2016
22 S2 p. e190-
1 p.
artikel
37 An explorative assessment of antioxidant and inflammatory biomarkers for identification of prodromal Parkinson's disease (PD) Campolo, Jonica
2016
22 S2 p. e30-e31
nvt p.
artikel
38 An explorative assessment of antioxidant and inflammatory biomarkers for identification of prodromal Parkinson's disease (PD) Campolo, Jonica
2016
22 S2 p. e26-
1 p.
artikel
39 An insight from the ayurvedic perspective of neurodegeneration Joy, Jibin
2016
22 S2 p. e15-
1 p.
artikel
40 An insight from the ayurvedic perspective of neurodegeneration Joy, Jibin
2016
22 S2 p. e88-
1 p.
artikel
41 A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease Choong, Chi-Jing
2016
22 S2 p. e191-
1 p.
artikel
42 A novel nonsense CAMTA1 mutation presenting as a tremor predominant phenotype Agarwal, Shashank
2016
22 S2 p. e174-
1 p.
artikel
43 Anthropometric equations to assess muscle mass in patients with spinocerebellar ataxia Teive, Helio
2016
22 S2 p. e150-
1 p.
artikel
44 Anthropometric profile of patients with spinocerebellar ataxia Teive, Helio
2016
22 S2 p. e149-e150
nvt p.
artikel
45 Antioxidant kinase inhibitors for LRRK2 Parkinson's disease Sharan, Priyankan
2016
22 S2 p. e166-e167
nvt p.
artikel
46 Antiparkinson and antioxidant effect of pyridylpyrazolinyl substituted heterosteroids in LPS induced neuroinflammation model of neurodegenerative disorders Singh, Ranjit
2016
22 S2 p. e186-
1 p.
artikel
47 Antiparkinson and antioxidant effect of pyridylpyrazolinyl substituted heterosteroids in LPS induced neuroinflammation model of neurodegenerative disorders Singh, Ranjit
2016
22 S2 p. e147-e148
nvt p.
artikel
48 An unexpected higher prevalence of Parkinson's disease in females than males in the province of Trento (Italy): a clues for the etiopathogenesis? Malaguti, Maria Chiara
2016
22 S2 p. e3-
1 p.
artikel
49 An unexpected higher prevalence of Parkinson's disease in females than males in the province of Trento (Italy): A clues for the etiopathogenesis? Malaguti, Maria Chiara
2016
22 S2 p. e29-
1 p.
artikel
50 Apathy is associated to altered resting-state functional connectivity and structural changes in Parkinson's disease Lucas-Jiménez, Olaia
2016
22 S2 p. e157-
1 p.
artikel
51 A pilot randomised controlled trial (RCT) of real-time fMRI neurofeedback and motor training for the treatment of Parkinson's Disease (PD) Subramanian, Leena
2016
22 S2 p. e70-
1 p.
artikel
52 Apocyanin, a microglial NADPH oxidase inhibitor prevents dopaminergic neuronal degeneration in lipopolysaccharide induced Parkinson's disease model Sharma, Neha
2016
22 S2 p. e187-
1 p.
artikel
53 A prospective study of cumulative incidence and course of RLS in de novo PD patients during chronic dopaminergic therapy Calzetti, Stefano
2016
22 S2 p. e54-
1 p.
artikel
54 A prospective study of cumulative incidence and course of RLS in de novo PD patients during chronic dopaminergic therapy Calzetti, Stefano
2016
22 S2 p. e7-
1 p.
artikel
55 A questionnaire survey of musician’s dystonia performed in a music college Konaka, Kuni
2016
22 S2 p. e136-
1 p.
artikel
56 Arterial spin labeling (ASL) may be useful for diagnosing existence of dementia in Parkinson's disease Abe, Kazuo
2016
22 S2 p. e160-
1 p.
artikel
57 Assessing the non-motor symptom burden progression in a longitudinal study of 411 Parkinson's patients, using the non-motor symptom questionnaire Grilo, Miguel
2016
22 S2 p. e38-
1 p.
artikel
58 Association between cancers and risk of Parkinson disease: A cohort study Piri, Reza
2016
22 S2 p. e33-
1 p.
artikel
59 Association between daytime sleepiness and the cholinergic ascending reticular activating system in Parkinson's disease Iijima, Mutsumi
2016
22 S2 p. e40-
1 p.
artikel
60 Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease Pisciotta, Maria Stella
2016
22 S2 p. e8-
1 p.
artikel
61 Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease Pisciotta, Maria Stella
2016
22 S2 p. e57-
1 p.
artikel
62 Association of mortalin (HSPA9) and other mitochondria-related genes with the risk of Parkinson's disease and Alzheimer's disease Chung, Sun Ju
2016
22 S2 p. e171-
1 p.
artikel
63 Association of Parkinson's disease (PD) with heterozygous carriers of the Wilson disease (WD) gene Ilyechova, Ekaterina
2016
22 S2 p. e175-
1 p.
artikel
64 Association of α-synuclein gene expression with Parkinson’s disease is attenuated with higher serum urate in the PPMI cohort Schwarzschild, Michael
2016
22 S2 p. e115-
1 p.
artikel
65 Association of TNF-alpha and IL-1beta genes polymorphism in Parkinson's disease Subramanium, Mohanadevi
2016
22 S2 p. e169-e170
nvt p.
artikel
66 A study of real life tolerability of rotigotine transdermal patch in Parkinson’s disease across all motor stages Barreto, Rui
2016
22 S2 p. e102-
1 p.
artikel
67 A study of real life tolerability of rotigotine transdermal patch in Parkinson’s disease across all motor stages Barreto, Rui
2016
22 S2 p. e20-
1 p.
artikel
68 A study to assess the health related quality of life and strains of caregivers of patients with Parkinson's disease Pullishery, Fawaz
2016
22 S2 p. e37-
1 p.
artikel
69 Atypical presentation of psychogenic movement disorder with jaw-opening dystonia: two cases reports Yoon, Won Tae
2016
22 S2 p. e137-
1 p.
artikel
70 Author Index 2016
22 S2 p. e193-e204
nvt p.
artikel
71 Autonomic disorders in Parkinson Disease Toshev, Jasur
2016
22 S2 p. e43-
1 p.
artikel
72 Autonomic dysfunction in Parkinson's disease associated with common glucocerebrosidase gene mutations Del Sorbo, Francesca
2016
22 S2 p. e44-
1 p.
artikel
73 Autonomic dysfunction in Parkinson's disease associated with common glucocerebrosidase gene mutations Del Sorbo, Francesca
2016
22 S2 p. e26-
1 p.
artikel
74 Bacopa monnieri supplements offset motor and co-morbid behavioral pathology, oxidative impairments and neurotoxicity in an chronic environmental toxin model of Parkinson's disease in mice Krishna, Gokul
2016
22 S2 p. e187-
1 p.
artikel
75 Baseline disease severity not predictive of sublingual apomorphine (APL-130277) dose needed to convert a PD patient from the off to on state Dubow, Jordan
2016
22 S2 p. e21-e22
nvt p.
artikel
76 Baseline disease severity not predictive of sublingual apomorphine (APL-130277) dose needed to convert a PD patient from the OFF to ON state Dubow, Jordan
2016
22 S2 p. e103-e104
nvt p.
artikel
77 Behavioral and psychological symptoms in Korean patients with early Parkinson's disease Ahn, Jinyoung
2016
22 S2 p. e55-e56
nvt p.
artikel
78 Beneficial role of voice inter-relating process and OM mantra enchanting in Parkinson's disease patients in south Delhi metro population Sharma, Vinod
2016
22 S2 p. e75-
1 p.
artikel
79 “Benign” GBA variants may alter gene splicing in South African Parkinson's disease cases Barkhuizen, Melinda
2016
22 S2 p. e172-
1 p.
artikel
80 Birth month and Parkinson's disease: Is there any relationship? Kurisaki, Ryoichi
2016
22 S2 p. e30-
1 p.
artikel
81 Blocking mitochondrial fission is protective in dopaminergic neuronal cells with inducible α-synuclein expression Fan, Rebecca Zhangqiuzi
2016
22 S2 p. e191-
1 p.
artikel
82 Blood biomarkers associated with cognitive decline in early stage and drug-naive Parkinson's disease patients Santiago, Jose
2016
22 S2 p. e8-
1 p.
artikel
83 Blood biomarkers associated with cognitive decline in early stage and drug-naive Parkinson's disease patients Santiago, Jose
2016
22 S2 p. e60-
1 p.
artikel
84 Blood lipid parameters in patients with Parkinson's disease Giyazitdinova, Elvina
2016
22 S2 p. e33-
1 p.
artikel
85 Brain network changes in relation to beginning apathy in PD patients Hatz, Florian
2016
22 S2 p. e142-
1 p.
artikel
86 Brain network changes in relation to beginning apathy in PD patients Hatz, Florian
2016
22 S2 p. e163-e164
nvt p.
artikel
87 Burden of mitochondrial DNA variations in Friedreich's Ataxia (FRDA) patients and sharing of mitochondrial lineage with Caucasians singh, Inder
2016
22 S2 p. e154-
1 p.
artikel
88 Caffeine intake and genetic susceptibility to Parkinson's disease Sharan, Priyankan
2016
22 S2 p. e173-
1 p.
artikel
89 Caffeine intake and genetic susceptibility to Parkinson's disease Sharan, Priyankan
2016
22 S2 p. e146-
1 p.
artikel
90 Can arm swing be clinical predictors of postural instability in Parkinson's Disease? Buated, Wannipat
2016
22 S2 p. e49-e50
nvt p.
artikel
91 Cancer comorbidity among Parkinson's Disease patients; a population based large-scale cohort study Gurel, Ron
2016
22 S2 p. e33-
1 p.
artikel
92 Cancer in Parkinson's disease Tacik, Pawel
2016
22 S2 p. e34-
1 p.
artikel
93 Can intraoperative clinical testing predict stimulation-induced effects of STN-DBS? Blume, Josefine
2016
22 S2 p. e107-
1 p.
artikel
94 Can intraoperative clinical testing predict stimulation-induced effects of STN-DBS? Blume, Josefine
2016
22 S2 p. e23-
1 p.
artikel
95 Can Quantitative EEG (QEEG) differentiate patients with Parkinson's disease (PD) from healthy controls? Chaturvedi, Menorca
2016
22 S2 p. e163-
1 p.
artikel
96 Cardiac sympathetic denervation predicts levodopa-induced dyskinesia in Patients with Parkinson's Disease Kang, Seok-Jae
2016
22 S2 p. e45-
1 p.
artikel
97 Case report: Multiple system atrophy C Fazzi, Larissa
2016
22 S2 p. e119-
1 p.
artikel
98 Cases of negative effect of chronic whole-body vibration on the dynamics of the flow and the quality of life in patients with Parkinson's disease Turgunkhujaev, Oybek
2016
22 S2 p. e67-
1 p.
artikel
99 Case study of sporadic multiple system atrophy at a young age Muinjonov, Bakhrom
2016
22 S2 p. e118-
1 p.
artikel
100 Case study of sporadic multiple system atrophy at a young age Muinjonov, Bakhrom
2016
22 S2 p. e76-
1 p.
artikel
101 Center of pressure displacement during gait initiation in individuals with Parkinson's disease Rigoldi, Chiara
2016
22 S2 p. e69-
1 p.
artikel
102 Center of pressure velocity and its fast alternating deviations as an objective measure of balance – Normal values and their sensitivity investigated in SCA patients Sobanska, Anna
2016
22 S2 p. e151-
1 p.
artikel
103 Center of pressure velocity and its fast alternating deviations as an objective measure of balance – Normal values and their sensitivity investigated in SCA patients Sobanska, Anna
2016
22 S2 p. e80-
1 p.
artikel
104 Centrifugal progression of TDP-43 pathology along olfactory pathway in ALS patients in contrast to centripetal progression of alpha-synuclein pathology in PD patients Takeda, Takahiro
2016
22 S2 p. e130-e131
nvt p.
artikel
105 Changes in maximum static force of knee extensors caused by prolonged whole body vibration training in Parkinson Disease patients Niewiadomski, Wiktor
2016
22 S2 p. e67-
1 p.
artikel
106 Changes in serum level of interferon-gamma, alpha tumor necrosis factor and autoantibodies in Parkinson's disease Giyazitdinova, Elvina
2016
22 S2 p. e32-e33
nvt p.
artikel
107 Changes of cerebral morphometry in patients with cerebrovascular and Parkinson's diseases Bogdanov, Rinat
2016
22 S2 p. e159-e160
nvt p.
artikel
108 Changes of resting state EEG in patients with left-sided and right-sided Parkinson's disease Kozhemiako, Nataliia
2016
22 S2 p. e35-
1 p.
artikel
109 Characteristic metabolic brain pattern in Slovenian Parkinson's disease patients Tomse, Petra
2016
22 S2 p. e83-e84
nvt p.
artikel
110 Characteristic metabolic brain pattern in Slovenian Parkinson's disease patients Tomse, Petra
2016
22 S2 p. e162-
1 p.
artikel
111 Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation Sharma, Neha
2016
22 S2 p. e186-
1 p.
artikel
112 Character of respiratory disorders in Parkinson's disease Toshev, Jasur
2016
22 S2 p. e47-
1 p.
artikel
113 Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease: Effects on motor and non motor symptoms with brain metabolism correlations Auffret, Manon
2016
22 S2 p. e85-
1 p.
artikel
114 Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease: Effects on motor and non motor symptoms with brain metabolism correlations Auffret, Manon
2016
22 S2 p. e102-e103
nvt p.
artikel
115 Classification of early stage Parkinson's disease in EEG and tremor time-frequency features space Sushkova, Olga
2016
22 S2 p. e164-
1 p.
artikel
116 Clinical and neuropathological features of rapid progressive dementia with Lewy Bodies Geut, A.J.
2016
22 S2 p. e115-e116
nvt p.
artikel
117 Clinical and neuropathological features of rapid progressive Dementia with Lewy Bodies Geut, A.J.
2016
22 S2 p. e85-e86
nvt p.
artikel
118 Clinical and objective evaluation of turning in floor squares of various sizes in patients with Parkinson's disease and healthy controls Stuhlinger, Lisa
2016
22 S2 p. e51-
1 p.
artikel
119 Clinical characteristics of Parkinson’s disease patients responsive to Istradefylline treatment Hazama, Takanori
2016
22 S2 p. e99-e100
nvt p.
artikel
120 Clinical correlates of depression and anxiety in patients with Parkinson's Disease Hambardzumyan, Hasmik
2016
22 S2 p. e56-
1 p.
artikel
121 Clinical course of migraine in Parkinson patients Lotfinia, Mahmoud
2016
22 S2 p. e45-
1 p.
artikel
122 Clinical impact of mood disorders on non-motor symptoms in Parkinson's disease Shinoda, Tomomi
2016
22 S2 p. e57-
1 p.
artikel
123 Clinical predictors of postural instability in Parkinson's Disease: the Nintendo Wii Balance Board Posturographic Study Lolekha, Praween
2016
22 S2 p. e50-e51
nvt p.
artikel
124 Clinical profile of Filipino patients with amyotrophic lateral sclerosis seen in a tertiary hospital: A 5 year-retrospective study Kristin Dale Moll, Mari Anne
2016
22 S2 p. e131-
1 p.
artikel
125 Clinical profile of hundred patients with Ataxia Telangiectasia from India Mahadevappa, Manjunath
2016
22 S2 p. e80-e81
nvt p.
artikel
126 Clinical profile of hundred patients with ataxia telangiectasia from India Mahadevappa, Manjunath
2016
22 S2 p. e153-e154
nvt p.
artikel
127 Clinical usefulness of F18-FP-CIT PET/CT in possible dementia with Lewy bodies: Preliminary study Ahn, Jin-Young
2016
22 S2 p. e116-
1 p.
artikel
128 Cognitive Behavioral Group Therapy (CBT) for stress reduction in patients with Parkinson's disease – a randomized control trial Hadinia, Anousha
2016
22 S2 p. e71-
1 p.
artikel
129 Cognitive Behavioral Group Therapy (CBT) for stress reduction in patients with Parkinson's disease – a randomized control trial Hadinia, Anousha
2016
22 S2 p. e12-e13
nvt p.
artikel
130 Cognitive disorders in Parkinsonism Karakhonova, S.A.
2016
22 S2 p. e59-
1 p.
artikel
131 Cognitive function in multiple system atrophy-C (cerebellar type) Yang, Youngsoon
2016
22 S2 p. e119-
1 p.
artikel
132 Cognitive impairment in Parkinson Disease is associated with reduced cerebrovascular reactivity Rubino, Alfonso
2016
22 S2 p. e59-
1 p.
artikel
133 Cognitive processing of sensory stimuli in cervical dystonia Chillemi, Gaetana
2016
22 S2 p. e136-
1 p.
artikel
134 Cognitive profile in non-demented GBA-carriers Parkinson's disease patients Siri, Chiara
2016
22 S2 p. e58-
1 p.
artikel
135 Colonic volume and gastrointestinal symptoms in Parkinson's disease Knudsen, Karoline
2016
22 S2 p. e46-
1 p.
artikel
136 Committees 2016
22 S2 p. e2-
1 p.
artikel
137 Comparative analysis of cognitive and affective disorders in vascular parkinsonism and Parkinson’s disease Djalilova, Sojida
2016
22 S2 p. e122-
1 p.
artikel
138 Comparative study of microrecording-based STN location and MRI-based STN location Verhagen, Rens
2016
22 S2 p. e108-
1 p.
artikel
139 Comparison of gait and cognitive function in the elderly with Alzheimer's disease dementia, mild cognitive impairment and normal control Moon, Seok Woo
2016
22 S2 p. e155-
1 p.
artikel
140 Comparison of non-motors symptoms in patients with spinocerebellar ataxia type 10 and type 3 Moro, Adriana
2016
22 S2 p. e150-
1 p.
artikel
141 Comparison of the antiparkinsonian and antidyskinetic effects of hemantane and amantadine Ivanova, Elena
2016
22 S2 p. e19-e20
nvt p.
artikel
142 Comparison of the antiparkinsonian and antidyskinetic effects of hemantane and amantadine Ivanova, Elena
2016
22 S2 p. e98-
1 p.
artikel
143 Compulsive eating and olfaction in Parkinson's Disease Gonçalves, Alexandra
2016
22 S2 p. e61-
1 p.
artikel
144 Computer aided movement analysis of MPTP mouse on inverted horizontal grid Niewiadomski, Wiktor
2016
22 S2 p. e183-
1 p.
artikel
145 Confocal laser microscopy and 3D reconstruction of Pick-like and ring-like inclusions in atypical multiple system atrophy Sikorska, Beata
2016
22 S2 p. e120-
1 p.
artikel
146 Continuous monitoring of PD with an affordable novel computerised motor test based on a tablet Da Lio, Mauro
2016
22 S2 p. e63-
1 p.
artikel
147 Continuous monitoring of PD with an affordable novel computerised motor test based on a tablet Da Lio, Mauro
2016
22 S2 p. e9-e10
nvt p.
artikel
148 Copper poisoning induces neurobehavioral features of Parkinson's disease in rat: Alters dopaminergic system and locomotor performance Abbaoui, Abdellatif
2016
22 S2 p. e188-
1 p.
artikel
149 Corpus callosum volumetry as a tool to differentiate subtypes of progressive supranuclear palsy Lenka, Abhishek
2016
22 S2 p. e121-e122
nvt p.
artikel
150 Correlation of the EEG frequency with cognitive performance in Parkinson's disease – Six-months follow-up Cozac, Vitalii
2016
22 S2 p. e164-
1 p.
artikel
151 Correlation of the EEG frequency with cognitive performance in Parkinson’s disease – six-months follow-up Cozac, Vitalii
2016
22 S2 p. e143-
1 p.
artikel
152 Cortical and subcortical neurodegeneration in chorea-acanthocytosis and Huntington’s disease: More differences than similarities Liu, Jia
2016
22 S2 p. e133-e134
nvt p.
artikel
153 Cortical and subcortical neurodegeneration in chorea-acanthocytosis and Huntington's disease: More differences than similarities Liu, Jia
2016
22 S2 p. e77-
1 p.
artikel
154 Cortisol measurements as a laboratory biomarker for stress reduction in Parkinson's disease (PD) patients Nowak, Karolina
2016
22 S2 p. e71-e72
nvt p.
artikel
155 Cortisol measurements as a laboratory biomarker for stress reduction in Parkinson's disease (PD) patients Nowak, Karolina
2016
22 S2 p. e13-
1 p.
artikel
156 c-Rel deficient mice, a mouse model of “spreading” PD-like pathology Parrella, Edoardo
2016
22 S2 p. e179-
1 p.
artikel
157 c-Rel deficient mice, a mouse model of “spreading” PD-like pathology Parrella, Edoardo
2016
22 S2 p. e146-
1 p.
artikel
158 Crossbreeding two mice strains with differential susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) positively modulates nigral dopaminergic phenotype Vidyadhara, D.J.
2016
22 S2 p. e183-
1 p.
artikel
159 CSF levels of heart fatty acid binding protein in Parkinson's and Alzheimer's disease Chiasserini, Davide
2016
22 S2 p. e33-
1 p.
artikel
160 Current status of the treatment with deep brain stimulation (DBS) conducted in Ehime, Japan Yabe, Hayato
2016
22 S2 p. e110-e111
nvt p.
artikel
161 Cytogenetic, genotypic, gene sequencing and gene expression studies on the stroke patients – A case control study Chandirasekar, Ramachandran
2016
22 S2 p. e175-
1 p.
artikel
162 Cytogenetic study and compared with measurements of oxidative stress and PINK1 gene in Parkinson Disease (PD) patients Fenn, James Pichai
2016
22 S2 p. e168-
1 p.
artikel
163 Cytogenic biomarkers and molecular study of PS1 gene in Alzheimer's disease in South Indian population Thangamani, Lokesh
2016
22 S2 p. e176-
1 p.
artikel
164 Deciphering the mechanism of cadmium induced brain dopaminergic dysfunctions and assess the protective potential of quercetin in rats Gupta, Richa
2016
22 S2 p. e188-
1 p.
artikel
165 Deep brain stimulation babies Scelzo, Emma
2016
22 S2 p. e113-
1 p.
artikel
166 Deep brain stimulation of STN for advanced Parkinson disease with octopolar leads: Programming electrical parameters guided for a neuroanatomical-3D-image software 12 months follow-up Salazar, Gabriel
2016
22 S2 p. e107-e108
nvt p.
artikel
167 Defective glucocerebrosidase in GBA1 mutant Parkinson's disease fibroblasts is rescued by chemical chaperone ambroxol through modulation of lysosomal factors Ambrosi, Giulia
2016
22 S2 p. e171-e172
nvt p.
artikel
168 Defective glucocerebrosidase in GBA1 mutant Parkinson's disease fibroblasts is rescued by chemical chaperone ambroxol through modulation of lysosomal factors Ambrosi, Giulia
2016
22 S2 p. e145-
1 p.
artikel
169 Deregulation of miRNAs 103a, 30b and 29a in peripheral blood of L-dopa treated Parkinson's patients Serafin, Alice
2016
22 S2 p. e189-e190
nvt p.
artikel
170 Description of cognitive disorders of Alzheimer's disease and Parkinson's disease Tolibov, Dilshod
2016
22 S2 p. e58-e59
nvt p.
artikel
171 Determination of minimal important difference thresholds for Parkinson’s disease Questionnaire-39 in advanced Parkinson’s disease patients Antonini, Angelo
2016
22 S2 p. e18-e19
nvt p.
artikel
172 Determination of minimal important difference thresholds for Parkinson’s disease questionnaire-39 in advanced Parkinson’s disease patients Antonini, Angelo
2016
22 S2 p. e95-e96
nvt p.
artikel
173 Development of a wireless sensor for tremors analysis Alimonti, Dario
2016
22 S2 p. e128-e129
nvt p.
artikel
174 Diagnosis of progressive supranuclear palsy in a memory clinic setting Nilsson, Christer
2016
22 S2 p. e120-
1 p.
artikel
175 Did Charcot have vascular parkinsonism? Teive, Helio
2016
22 S2 p. e123-
1 p.
artikel
176 Differences between apomorphine (APO) and lisuride (LIS) in PD therapy Horowski, Reinhard
2016
22 S2 p. e104-e105
nvt p.
artikel
177 Differences between apomorphine (APO) and lisuride (LIS) in PD therapy Horowski, Reinhard
2016
22 S2 p. e22-
1 p.
artikel
178 Differential induction of dyskinesia and inflammatory responses by intermittent versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease Carta, Anna R.
2016
22 S2 p. e79-
1 p.
artikel
179 Differential induction of dyskinesia and inflammatory responses by intermittent versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease. Carta, Anna R.
2016
22 S2 p. e115-
1 p.
artikel
180 Distal hereditary motor neuropathy with HSJ1 chaperone mutation, presenting with peripheral motor neuropathy, associated to parkinsonism, and cerebellar ataxia. Case report Teive, Helio
2016
22 S2 p. e154-
1 p.
artikel
181 Distribution, metabolism and elimination of opicapone in the rat and non-human primates Loureiro, Ana I.
2016
22 S2 p. e184-
1 p.
artikel
182 DNAJC6 mutations associated with early-onset Parkinson's disease Olgiati, Simone
2016
22 S2 p. e144-
1 p.
artikel
183 DNAJC6 mutations associated with early-onset Parkinson's disease Olgiati, Simone
2016
22 S2 p. e168-
1 p.
artikel
184 Does premorbid educational attainment modify motor compensation in Parkinson's Disease? Sohn, Young H.
2016
22 S2 p. e65-
1 p.
artikel
185 Dopaminergic dysfunction and cognitive impairment in Parkinson's disease: Evidence from a SPECT study in a large cohort of de-novo patients Frosini, Daniela
2016
22 S2 p. e161-
1 p.
artikel
186 Dopaminergic medicines are drugs of choice for medicament-resistant facial nerve neuropathy Azimov, Anvar
2016
22 S2 p. e139-e140
nvt p.
artikel
187 Dopaminergic medicines are drugs of choice for medicament-resistant facial nerve neuropathy: EMG study Azimov, Anvar
2016
22 S2 p. e140-
1 p.
artikel
188 Dopaminergic therapy: on a number of complications as increasing of libido in patients with Parkinson's disease and Parkinson’s syndrome Mirdedaev, Sanjar
2016
22 S2 p. e90-
1 p.
artikel
189 Dyskinesia and L-dopa treatment Nunomura, Jin-ichi
2016
22 S2 p. e90-
1 p.
artikel
190 Dysphagia, pneumonia and hospital admissions in Parkinson's Disease: a multicentre observational study Moti, Elisavet
2016
22 S2 p. e47-e48
nvt p.
artikel
191 DYT16/PRKRA founder mutation causes childhood-onset generalized dystonia in a family from Southern Italy Quadri, Marialuisa
2016
22 S2 p. e77-e78
nvt p.
artikel
192 DYT16/PRKRA founder mutation causes childhood-onset generalized dystonia in a family from Southern Italy Quadri, Marialuisa
2016
22 S2 p. e135-e136
nvt p.
artikel
193 Editorial Board 2016
22 S2 p. e1-
1 p.
artikel
194 EEG features of dyskinesias, complicated by levodopa therapy in patients with Parkinson's disease. Askhonov, Ulugbek
2016
22 S2 p. e143-
1 p.
artikel
195 EEG features of dyskinesias, complicated by levodopa therapy in patients with Parkinson's disease Askhonov, Ulugbek
2016
22 S2 p. e165-
1 p.
artikel
196 Effect of bilateral subthalamic DBS on gait in patients with idiopathic Parkinson's disease Borgohain, Rupam
2016
22 S2 p. e106-
1 p.
artikel
197 Effect of electroconvulsive therapy on visuospatial memory in rats Lakkappa, Navya
2016
22 S2 p. e177-e178
nvt p.
artikel
198 Effect of high versus low frequency subthalamic nucleus deep brain stimulation in Freezing of Gait Asaadi, Sina
2016
22 S2 p. e108-
1 p.
artikel
199 Effect of metal ions on aggregation of amyloid beta peptide Abbaskhani, Zahra
2016
22 S2 p. e191-e192
nvt p.
artikel
200 Effect of pharmacist-led interventions on motor symptoms in Parkinson's patients: A pilot study Stuijt, Clementine
2016
22 S2 p. e87-e88
nvt p.
artikel
201 Effect of pharmacist-led interventions on motor symptoms in Parkinson's patients: A pilot study Stuijt, Clementine
2016
22 S2 p. e27-e28
nvt p.
artikel
202 Effect of rhythmic auditory stimulation on gait in patients with stroke Fouad, Mohamed
2016
22 S2 p. e125-
1 p.
artikel
203 Effects of Arachidonyl-2′-chloroethylamide (ACEA) as a CB1 receptor agonist in the rat model of Parkinson's disease Omidbeigi, Mahmoud
2016
22 S2 p. e147-
1 p.
artikel
204 Effects of Arachidonyl-2′-chloroethylamide (ACEA) as a CB1 receptor agonist in the rat model of Parkinson's disease Omidbeigi, Mahmoud
2016
22 S2 p. e182-
1 p.
artikel
205 Effects of cognitive loading on standing balance and postural stability in Parkinson's disease patients with freezing of gait Buated, Wannipat
2016
22 S2 p. e72-e73
nvt p.
artikel
206 Effects of Cognitive Loading on Standing Balance and Postural Stability in Parkinson's Disease Patients with Freezing of Gait Buated, Wannipat
2016
22 S2 p. e13-e14
nvt p.
artikel
207 Effects of levodopa-carbidopa intestinal gel on non-motor symptoms and safety of outpatient titration: A new phase 3 study in patients with advanced Parkinson's disease Standaert, David
2016
22 S2 p. e94-e95
nvt p.
artikel
208 Effects of levodopa-carbidopa intestinal gel on non-motor symptoms and safety of outpatient titration: A new phase 3 study in patients with advanced Parkinson's disease Standaert, David
2016
22 S2 p. e17-e18
nvt p.
artikel
209 Effects of Parkinson's disease on cognitive action control: insights on impulsive response tendencies using an oculomotor Simon task. Duprez, Joan
2016
22 S2 p. e61-e62
nvt p.
artikel
210 Effects of Parkinson's disease on cognitive action control: Insights on impulsive response tendencies using an oculomotor Simon task Duprez, Joan
2016
22 S2 p. e8-e9
nvt p.
artikel
211 Effects of trunk proprioceptive neuromuscular facilitation on dynamic balance, mobility and quality of life in Parkinson's disease Sneha, B.S.
2016
22 S2 p. e68-e69
nvt p.
artikel
212 Effects of virtual reality exercise program on balance in lower parkinsonism patients Lee, Geun-Ho
2016
22 S2 p. e70-
1 p.
artikel
213 Efficacy and safety of istradefylline for the treatment of non-motor symptoms and quality of life (QOL) in patients with Parkinson's disease Abe, Kazuo
2016
22 S2 p. e99-
1 p.
artikel
214 Efficacy and safety of istradefylline for the treatment of non-motor symptoms and quality of life (QOL) in patients with Parkinson's disease and QOL in their caregivers Abe, Kazuo
2016
22 S2 p. e100-
1 p.
artikel
215 Efficacy and tolerability of NUPLAZID™ (pimavanserin) in PD Psychosis: Analysis of an integrated Phase 3 placebo-controlled dataset Mills, Roger
2016
22 S2 p. e92-
1 p.
artikel
216 Efficacy of rasagiline in PD patients with mild cognitive impairment Weintraub, Daniel
2016
22 S2 p. e91-
1 p.
artikel
217 Efficacy of sublingual apomorphine (APL-130277) for the treatment of off episodes in patients with Parkinson's disease Agro, Albert
2016
22 S2 p. e21-
1 p.
artikel
218 Efficacy of sublingual apomorphine (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease Agro, Albert
2016
22 S2 p. e103-
1 p.
artikel
219 Electromyographic diagnostics in Parkinson's disease and detection of relatives of patients at risk Ayupova, Dilorom
2016
22 S2 p. e143-
1 p.
artikel
220 Electromyographic diagnostics in Parkinson's disease and detection of relatives of patients at risk Ayupova, Dilorom
2016
22 S2 p. e165-
1 p.
artikel
221 Emotion recognition and emotion expression in Parkinson's disease: An unifying emotional mirror mechanism? Ricciardi, Lucia
2016
22 S2 p. e7-
1 p.
artikel
222 Emotion recognition and emotion expression in Parkinson's disease: An unifying emotional mirror mechanism? Ricciardi, Lucia
2016
22 S2 p. e55-
1 p.
artikel
223 Enteric fever presenting as catatonia and parkinsonism : An unusual presentation Jaiswal, Shyam K.
2016
22 S2 p. e126-e127
nvt p.
artikel
224 Epigenetics role in Parkinson's disease Dehbashi, Moein
2016
22 S2 p. e166-
1 p.
artikel
225 Epigenome-wide DNA methylation analysis in brothers and monozygotic twins discordant for Parkinson’s disease Kaut, Oliver
2016
22 S2 p. e86-
1 p.
artikel
226 Epigenome-wide DNA methylation analysis in brothers and monozygotic twins discordant for Parkinson's disease Kaut, Oliver
2016
22 S2 p. e172-
1 p.
artikel
227 Estimation of skeletal muscle mass in patients with spinocerebellar ataxia. Teive, Helio
2016
22 S2 p. e150-
1 p.
artikel
228 Evaluation of clinical phenotypes associated with cytogenetic effects and Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms in Parkinson disease in Coimbatore region, South India Iyer, Mahalakshmi
2016
22 S2 p. e170-
1 p.
artikel
229 Evaluation of genetic load in early-onset Parkinson's disease patients by next-generation sequencing Seresini, Agostino
2016
22 S2 p. e169-
1 p.
artikel
230 Evaluation of serum amino acid profile in patients with advanced Parkinson's disease. Figura, Monika
2016
22 S2 p. e35-e36
nvt p.
artikel
231 Evaluation of spatiotemporal parameters in Parkinson's disease and their correlation with UPDRS motor score. About 32 cases Kadi, Djamila
2016
22 S2 p. e52-
1 p.
artikel
232 Evidence of heavy metals implication in Parkinson disease: Involvement of serotonin and the beneficial therapeutic role of curcumin Benammi, Hind
2016
22 S2 p. e185-
1 p.
artikel
233 Exercising is reducing anxiety, depression and memory deficits induced by a MPTP-induced rat model of Parkinson's disease Ciobica, Alin
2016
22 S2 p. e183-
1 p.
artikel
234 Exogenous salsolinol influences gut-brain axis Kurnik, Magdalena
2016
22 S2 p. e186-
1 p.
artikel
235 Exome sequencing in a family with autosomal-recessive mental retardation, polyneuropathy, ataxia and epilepsy Hor, Hyun
2016
22 S2 p. e174-
1 p.
artikel
236 Experimental model of extrapyramidal disorders caused by reserpine Tursunov, Djakhangir
2016
22 S2 p. e185-e186
nvt p.
artikel
237 Exploring the grey matter correlates of Wilson's disease using voxel based morphometry Sunny, Albert Stezin
2016
22 S2 p. e160-
1 p.
artikel
238 Facial emotion recognition in Parkinson's disease Kalampokini, Stefania
2016
22 S2 p. e55-
1 p.
artikel
239 Factors influencing the falls in patients with Parkinson's disease Skripkina, Natalia
2016
22 S2 p. e53-
1 p.
artikel
240 Falling direction is important predictors for mechanism of falls in patients with Parkinson’s disease Youn, Jinyoung
2016
22 S2 p. e5-
1 p.
artikel
241 Falling direction is important predictors for mechanism of falls in patients with Parkinson's Disease Youn, Jinyoung
2016
22 S2 p. e53-
1 p.
artikel
242 Falls in Parkinson's disease: Effects on health related quality of life Farombi, Temitope
2016
22 S2 p. e6-
1 p.
artikel
243 Falls in Parkinson's disease: effects on health related quality of life Farombi, Temitope
2016
22 S2 p. e54-
1 p.
artikel
244 Fatigue in Parkinson's disease and striatum dopamine transporter scan (DaTscan) uptake Sauerbier, Anna
2016
22 S2 p. e83-
1 p.
artikel
245 Fatigue in Parkinson's disease and striatum dopamine transporter scan (DaTscan) uptake Sauerbier, Anna
2016
22 S2 p. e161-e162
nvt p.
artikel
246 Favourable effect of safinamide on mood over 2-year treatment of fluctuating Parkinson’s disease patients Cattaneo, Carlo
2016
22 S2 p. e98-e99
nvt p.
artikel
247 Features neuroimaging and neurological disorders in Alzheimer's disease with parkinsonism Tolibov, Dilshod
2016
22 S2 p. e162-e163
nvt p.
artikel
248 Fine motor function skills in patients with Parkinson disease (PD) with and without mild cognitive impairment (MCI) Dahdal, Philippe
2016
22 S2 p. e62-
1 p.
artikel
249 Fine motor function skills in patients with Parkinson disease (PD) with and without mild cognitive impairment (MCI) Dahdal, Philippe
2016
22 S2 p. e9-
1 p.
artikel
250 Frequency and risk of falls in Parkinson’s disease in Ibadan Farombi, Temitope
2016
22 S2 p. e5-e6
nvt p.
artikel
251 Frequency and risk of falls in Parkinson's disease in Ibadan Farombi, Temitope
2016
22 S2 p. e53-e54
nvt p.
artikel
252 Frequency and sleep stage sequence of SOREM periods in Parkinson's disease Murer, Tobias
2016
22 S2 p. e39-
1 p.
artikel
253 Frequency of the pain and sleep problems in dystonia patients and influence of deep brain stimulation Vuletic, Vladimira
2016
22 S2 p. e78-
1 p.
artikel
254 Frequency of the pain and sleep problems in dystonia patients and influence of deep brain stimulation. Vuletic, Vladimira
2016
22 S2 p. e136-e137
nvt p.
artikel
255 Functional connectivity underpinnings of fatigue in “drug-naïve” patients with Parkinson’s disease Giordano, Alfonso
2016
22 S2 p. e142-
1 p.
artikel
256 Functional connectivity underpinnings of fatigue in “drug-naïve” patients with Parkinson's disease Giordano, Alfonso
2016
22 S2 p. e164-
1 p.
artikel
257 Gait analysis in Parkinson’s disease assessing the effect of levodopa using a validated electronic walkway Mondal, Banashree
2016
22 S2 p. e89-
1 p.
artikel
258 Gastroesophageal dysmotility in advanced Parkinson's Disease Mancini, Francesca
2016
22 S2 p. e46-
1 p.
artikel
259 Gastroesophageal dysmotility in advanced Parkinson’s disease Mancini, Francesca
2016
22 S2 p. e4-
1 p.
artikel
260 Gastrointestinal safety of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients: GLORIA long-term registry interim results Domagk, Dirk
2016
22 S2 p. e19-
1 p.
artikel
261 Gastrointestinal safety of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients: GLORIA long-term registry interim results Domagk, Dirk
2016
22 S2 p. e96-e97
nvt p.
artikel
262 Gastrointestinal symptom is a significant indicator of nigrostriatal dopaminergic degeneration in idiopathic REM sleep behavior disorder patients Lee, Jee-Young
2016
22 S2 p. e117-
1 p.
artikel
263 Generation and characterization of iPSC-derived cortical pyramidal neurons from patients affected by multiple system atrophy Compagnoni, Giacomo Monzio
2016
22 S2 p. e119-e120
nvt p.
artikel
264 Genetic models of Parkinson's disease Dehbashi, Moein
2016
22 S2 p. e179-
1 p.
artikel
265 High fat diet feeding exacerbates the toxic effects of 6-hydroxydopamine in rats: Possible involvement of histone acetylation Sharma, Sorabh
2016
22 S2 p. e181-
1 p.
artikel
266 High frequency repetitive transcranial magnetic stimulation can improve the quality of life and depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study Kovács, Norbert
2016
22 S2 p. e109-
1 p.
artikel
267 High frequency repetitive transcranial magnetic stimulation can improve the quality of life and depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study Kovács, Norbert
2016
22 S2 p. e23-e24
nvt p.
artikel
268 HMG-CoA reductase inhibitors-induced cerebellar ataxia. A Brazilian case series Moro, Adriana
2016
22 S2 p. e155-
1 p.
artikel
269 Hospital-based study on emergency admission in patients with Parkinson's disease Fujioka, Shinsuke
2016
22 S2 p. e36-e37
nvt p.
artikel
270 Hospitalisation coding errors in Parkinson's disease in a large UK teaching hospital Muzerengi, Sharon
2016
22 S2 p. e36-
1 p.
artikel
271 Hospitalisation in early Parkinson's disease using Hospital Episodes Statistics from the PD MED trial Muzerengi, Sharon
2016
22 S2 p. e36-
1 p.
artikel
272 H-3 Receptor Antagonist and JNK-3 Inhibitor: A new therapeutic approach to treat Parkinson’s disease Ambhore, Nilesh
2016
22 S2 p. e91-
1 p.
artikel
273 Hyperkinesia in ancient China: Perspectives and prescriptions Liu, Jia
2016
22 S2 p. e76-e77
nvt p.
artikel
274 Hyperkinesia in ancient China: Perspectives and prescriptions Liu, Jia
2016
22 S2 p. e133-
1 p.
artikel
275 Hyposmia in progressive supranuclear palsy Muinjonov, Bakhrom
2016
22 S2 p. e120-
1 p.
artikel
276 Identification and verification of novel FBXO7 interacting proteins Mandemakers, Wim
2016
22 S2 p. e171-
1 p.
artikel
277 Identification of chromosomal alteration and association study of neuroligins and neurexins gene polymorphisms with Alzheimer disease (ad) patients in Coimbatore population, TamilNadu, India Srinivasan, Shanthkriti
2016
22 S2 p. e176-
1 p.
artikel
278 Identification of novel PD genes by whole-exome sequencing in Italian families Straniero, Letizia
2016
22 S2 p. e144-
1 p.
artikel
279 Identification of novel PD genes by whole-exome sequencing in Italian families Straniero, Letizia
2016
22 S2 p. e166-
1 p.
artikel
280 Identification of the Globus Pallidus interna based on time patterns analysis in Parkinson's disease Andres, Daniela Sabrina
2016
22 S2 p. e165-e166
nvt p.
artikel
281 Identification of the Globus Pallidus interna based on time patterns analysis in Parkinson's disease Andres, Daniela Sabrina
2016
22 S2 p. e143-e144
nvt p.
artikel
282 Idiopathic very late-onset cerebellar ataxia: A Brazilian case series Teive, Helio
2016
22 S2 p. e149-
1 p.
artikel
283 IL-1beta induces MMP-9 expression associated with cell migration via NOX2-derived ROS signals in rat brain astrocytes Yang, Chuen-Mao
2016
22 S2 p. e191-
1 p.
artikel
284 Impact of an interdisciplinary deep brain stimulation screening model on post-surgical complications in essential tremor patients Higuchi, Masa-Aki
2016
22 S2 p. e130-
1 p.
artikel
285 Impact of current antipsychotic medications on comparative mortality and adverse events in people with Parkinson’s disease psychosis (PDP) Mills, Roger
2016
22 S2 p. e91-e92
nvt p.
artikel
286 Impact of gait and balance training on advanced Parkinson's Disease patients after bilateral STN-DBS Vani Kagita, Venkata Padma
2016
22 S2 p. e111-e112
nvt p.
artikel
287 Impact of gender on impulse control disorders and other non-motor symptoms among Parkinson's disease patients Kovács, Norbert
2016
22 S2 p. e8-
1 p.
artikel
288 Impact of gender on impulse control disorders and other non-motor symptoms among Parkinson's disease patients Kovács, Norbert
2016
22 S2 p. e60-e61
nvt p.
artikel
289 Impact of the whole body vibration training on activity of daily living and quality of life in Parkinson Disease patients Karbowniczek, Aleksandra
2016
22 S2 p. e67-
1 p.
artikel
290 Impact of the whole body vibration training on the motor symptoms in Parkinson Disease patients Karbowniczek, Aleksandra
2016
22 S2 p. e66-e67
nvt p.
artikel
291 Implication of CD4 for the progression of parkinsonism in patients with lupus erythematosus Bebitov, Sarvar
2016
22 S2 p. e126-
1 p.
artikel
292 Improvement of cognitive performance and cholinergic transmission by development of novel acridine-piperazine hybrids Sharma, Anuradha
2016
22 S2 p. e178-
1 p.
artikel
293 Impulse control disorders and punding in Perry syndrome Mishima, Takayasu
2016
22 S2 p. e127-
1 p.
artikel
294 Impulse control disorders in Parkinson's disease and effect of bilateral STN DBS on them Kandadai, Rukmini Mridula
2016
22 S2 p. e112-
1 p.
artikel
295 Impulsive-compulsive behaviors in Parkin-associated Parkinson's disease: a case-control study Morgante, Francesca
2016
22 S2 p. e26-e27
nvt p.
artikel
296 Impulsive-compulsive behaviors in Parkin-associated Parkinson's disease: a case-control study Morgante, Francesca
2016
22 S2 p. e61-
1 p.
artikel
297 4i (N-(3-Chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist alleviates depressive behavior evoked in streptozotocin-induced diabetic mice: Role of oxidative stress Gupta, Deepali
2016
22 S2 p. e177-
1 p.
artikel
298 Increased density of large calretinin expressing interneurons in the striatum of Parkinsonian monkeys Petryszyn, Sarah
2016
22 S2 p. e182-
1 p.
artikel
299 Increased serotonin innervation of the sensorimotor striatum in a primate model of Parkinson's disease Gagnon, Dave
2016
22 S2 p. e181-e182
nvt p.
artikel
300 Infections related to deep brain stimulation in patients with Parkinson’s disease: Clinical characteristics and risk factors Kim, Mi Sun
2016
22 S2 p. e113-
1 p.
artikel
301 Inhaled steroid induced hemichorea-hemiballism Kim, Hee Jin
2016
22 S2 p. e134-
1 p.
artikel
302 Inhibition of PERK and NFKB pathway can reduce death of stressed dopaminergic neurons differentiated from human stem cell line Chaudhry, Zahara L.
2016
22 S2 p. e148-
1 p.
artikel
303 Inhibition of PERK and NFKB pathway can reduce death of stressed dopaminergIC neurons differentiated from human stem cell line Chaudhry, Zahara L.
2016
22 S2 p. e190-
1 p.
artikel
304 Insomnia in Parkinson's disease Muinjonov, Bakhrom
2016
22 S2 p. e40-
1 p.
artikel
305 Integration of cortical and basal ganglia inputs in motor thalamus of parkinsonian animal models Orban, Gerg
2016
22 S2 p. e180-
1 p.
artikel
306 Integration of cortical and basal ganglia inputs in motor thalamus of parkinsonian animal models Orban, Gerg
2016
22 S2 p. e147-
1 p.
artikel
307 Interaction between a GWAS-linked genetic variant and caffeine intake in Parkinson's disease Cheng, Yu Ching
2016
22 S2 p. e173-
1 p.
artikel
308 Interaction between caffeine intake and N-acetyltransferase 2 genotype in Parkinson's disease Lim, Jing Wei
2016
22 S2 p. e173-
1 p.
artikel
309 Interoceptive awareness in patients with functional motor disorders Demartini, Benedetta
2016
22 S2 p. e80-
1 p.
artikel
310 Interoceptive awareness in patients with functional motor disorders Demartini, Benedetta
2016
22 S2 p. e141-
1 p.
artikel
311 Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in PD Hirayama, Masaaki
2016
22 S2 p. e32-
1 p.
artikel
312 Intraventricular tumour presenting as progressive supranuclear palsy-like phenotype Morelli, Maurizio
2016
22 S2 p. e34-
1 p.
artikel
313 Iodine-123-FP-CIT SPECT in familial parkinsonism Onuma, Saori
2016
22 S2 p. e161-
1 p.
artikel
314 Is cognitive function influenced to the self-assessment about the psychological symptom in PD? Kumon, Aya
2016
22 S2 p. e58-
1 p.
artikel
315 Is decreased hand dexterity a reason for poor oral hygiene in Parkinson's disease? Pullishery, Fawaz
2016
22 S2 p. e9-
1 p.
artikel
316 Is decreased hand dexterity a reason for poor oral hygiene in Parkinson's Disease? Pullishery, Fawaz
2016
22 S2 p. e62-
1 p.
artikel
317 Is emotional prosody of speech affected by quality of life and depression in bilateral sub-thalamic nucleus deep brain stimulation (STN-DBS) of Parkinson’s disease? Majdinasab, Fatemeh
2016
22 S2 p. e112-
1 p.
artikel
318 Is the mechanism of nervous cells death in Parkinson different than in other neurodegenerations – Arguments from MRI study? Friedman, Andrzej
2016
22 S2 p. e82-
1 p.
artikel
319 Is the mechanism of nervous cells death in Parkinson different than in other neurodegenerations – Arguments from MRI study? Friedman, Andrzej
2016
22 S2 p. e156-e157
nvt p.
artikel
320 Is there any relationship between olfactory dysfunction and depression in Parkinson's disease? Hasegawa, Kazuko
2016
22 S2 p. e56-e57
nvt p.
artikel
321 Istradefylline Parkinson's disease trial: Methodology of data quality Cantillon, Marc
2016
22 S2 p. e99-
1 p.
artikel
322 Istradefylline Parkinson's disease trial: Methodology of data quality Cantillon, Marc
2016
22 S2 p. e20-
1 p.
artikel
323 Italian survey on intraduodenal levodopa gel treatment in advanced Parkinson disease: State of the art 10 years after marketing Sensi, Mariachiara
2016
22 S2 p. e97-e98
nvt p.
artikel
324 I2020T LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3beta signaling pathway Ohta, Etsuro
2016
22 S2 p. e167-
1 p.
artikel
325 Japanese Longitudinal Biomarker Study in PSP and CBD (JALPAC): A prospective multicenter PSP/CBD cohort study in Japan Takigawa, Hiroshi
2016
22 S2 p. e120-e121
nvt p.
artikel
326 Labyrinth diseases in autosomal recessive ataxia Zeigelboim, Bianca Simone
2016
22 S2 p. e152-
1 p.
artikel
327 Late onset Wilson’s disease with central pontine and extrapontine MRI changes Biller, Tara
2016
22 S2 p. e140-
1 p.
artikel
328 Learning Rhythm: an innovative multifunctional neuro-rehabilitative method to improve cognitive performances in Parkinson's Disease patients Minella, Stella
2016
22 S2 p. e73-
1 p.
artikel
329 Level of S100B protein in blood plasma depends on the form of Parkinson's disease Juraev, Mirzo
2016
22 S2 p. e32-
1 p.
artikel
330 Levodopa-carbidopa intestinal gel treatment in patients with <10 years of Parkinson's disease: GLORIA registry interim results Antonini, Angelo
2016
22 S2 p. e93-e94
nvt p.
artikel
331 Lewy body disease as pure autonomic failure with more than 20 years history: A post mortem study Oiwa, Kotaro
2016
22 S2 p. e117-
1 p.
artikel
332 Longer duration of Parkinson's disease is associated with reduced prevalence of hypertension Brandi, Vincenzo
2016
22 S2 p. e45-
1 p.
artikel
333 Longer duration of Parkinson's disease is associated with reduced prevalence of hypertension Brandi, Vincenzo
2016
22 S2 p. e3-
1 p.
artikel
334 Longitudinal study of the effect of a combined exercise program (land and water) on the physical condition in elderly with Parkinson's disease Mendez-Rial, Belia
2016
22 S2 p. e67-e68
nvt p.
artikel
335 Long-term effectiveness of NUPLAZID™ (pimavanserin) in PD psychosis: Data from 2 open-label studies Mills, Roger
2016
22 S2 p. e28-
1 p.
artikel
336 Long-term effectiveness of NUPLAZID™ (pimavanserin) in PD psychosis: Data from 2 open-label studies Mills, Roger
2016
22 S2 p. e92-e93
nvt p.
artikel
337 LRRK2 and GBA mutation analysis in a cohort of Italian familial and sporadic PD Trezzi, Ilaria
2016
22 S2 p. e167-
1 p.
artikel
338 Lysosomal enzyme activities in postmortem brain tissue of patients with Lewy body diseases Moors, Tim
2016
22 S2 p. e116-
1 p.
artikel
339 Magnetic resonance characteristic of Parkinson's disease based on the presence of cognitive impairment Bonu, Doniyorova Farangis
2016
22 S2 p. e159-
1 p.
artikel
340 Magnetic resonance characteristics of Parkinson's disease based on the presence of cognitive impairments Okiljonova, Nigoraxon
2016
22 S2 p. e158-
1 p.
artikel
341 Mayo Clinic Florida Morris K. Udall Center of Excellence for Parkinson's Research Strongosky, Audrey
2016
22 S2 p. e166-
1 p.
artikel
342 Mentally and emotional disorders of Parkinson's Disease Khasanova, Kamola
2016
22 S2 p. e55-
1 p.
artikel
343 Meta-analysis: Donepezil in the treatment of cognitive impairment & dementia in patients with Parkinson’s disease Barcelon, Ela
2016
22 S2 p. e101-
1 p.
artikel
344 Methylmalonic acid is an important factor that cause peripheral neuropathy in Idiopathic Parkinson's disease Park, Jin-Sung
2016
22 S2 p. e63-e64
nvt p.
artikel
345 Minimum MDS-UPDRS part III change needed to convert a Parkinson's disease patient from the OFF to full ON state with sublingual apomorphine (APL-130277) Dubow, Jordan
2016
22 S2 p. e104-
1 p.
artikel
346 Minimum MDS-UPDRS part III change needed to convert a Parkinson's disease patient from the off to full on state with sublingual apomorphine (APL-130277) Dubow, Jordan
2016
22 S2 p. e22-
1 p.
artikel
347 MoCA vs. MMSE sensitivity as screening instruments of cognitive impairment in PD, MSA and PSP patients Fiorenzato, Eleonora
2016
22 S2 p. e59-e60
nvt p.
artikel
348 Modulation of the glial response via the platelet-derived growth factor receptors (PDGFR) on the diencephalic dopaminergic neurons in zebrafish larvae Norazit, Anwar
2016
22 S2 p. e180-
1 p.
artikel
349 Mortality of advanced Parkinson's disease patients who received deep brain stimulation surgery Ryu, Ho-Sung
2016
22 S2 p. e112-e113
nvt p.
artikel
350 Motor and cognitive deterioration in advanced young-onset PD: A cautionary tale Kriznar, Nina Zupancic
2016
22 S2 p. e35-
1 p.
artikel
351 Movement disorders after stroke in third level hospital Marrakech morocco Chahidi, Abderrahmane
2016
22 S2 p. e123-e124
nvt p.
artikel
352 Multicenter experience of mixed deep brain stimulation implants for movement disorders Preda, Francesca
2016
22 S2 p. e105-e106
nvt p.
artikel
353 Myokymia revealing multiple sclerosis Tibar, Houyam
2016
22 S2 p. e131-e132
nvt p.
artikel
354 NcRNAs, Nutrition and Brain disorders Dehbashi, Moein
2016
22 S2 p. e176-
1 p.
artikel
355 Neurofeedback in Parkinson's Disease Esmail, Sanad
2016
22 S2 p. e70-
1 p.
artikel
356 Neuroleptic induced dyskinesia or…? Harutyunyan, Kristina
2016
22 S2 p. e135-
1 p.
artikel
357 Neuroophthalmic disorders in children with cerebral palsy Abdukadirova, Ikbol
2016
22 S2 p. e123-
1 p.
artikel
358 Neuroprotective effect of ethanolic extract of Pandanus Odoratissimus Ln. in Paraquat mice model of Parkinson's disease Sitepu, Enda Cindylosa
2016
22 S2 p. e187-
1 p.
artikel
359 Neuropsychological assessment in patients with Parkinson's disease associated with PARK2 gene mutations: A case-control study Amami, Paolo
2016
22 S2 p. e167-e168
nvt p.
artikel
360 Neurotoxic alterations in pesticide exposed population: A preliminary study Yadav, Rajesh Singh
2016
22 S2 p. e128-
1 p.
artikel
361 New opportunities for innovation and internet technologies in rehabilitation of patients with Parkinson's disease in the Aral Sea region of the Republic of Uzbekistan Izyumova, Gulbakhar
2016
22 S2 p. e75-
1 p.
artikel
362 Nigrostriatal degeneration dictates a top-down genetic program for neuroplasticity and neurorepair: Focus on the hippocampus and Wnt/GSK-3β/β-catenin signaling cascade Marchetti, Bianca
2016
22 S2 p. e183-e184
nvt p.
artikel
363 Nigrostriatal dopamine-independent resting-state functional networks in Parkinson's disease Lee, Phil Hyu
2016
22 S2 p. e163-
1 p.
artikel
364 Non-invasive biomarkers for spinocerebellar ataxias, types 2 & 12 patients and their correlation with cerebellar degeneration Moganty, Rajeswari R.
2016
22 S2 p. e152-e153
nvt p.
artikel
365 Non motor symptoms impact quality of life (QOL) in de novo Parkinson's disease (PD) Toyoda, Chizuko
2016
22 S2 p. e37-e38
nvt p.
artikel
366 Novel compound heterozygous mutations of PLA2G6 in a Korean pedigree of young-onset Parkinson's disease: A study of whole genome sequencing Choi, Eu Gene
2016
22 S2 p. e168-e169
nvt p.
artikel
367 Novel GNAL mutation with intra-familial clinical heterogeneity: Expanding the phenotype Carecchio, Miryam
2016
22 S2 p. e135-
1 p.
artikel
368 Novel GNAL mutation with intra-familial clinical heterogeneity: Expanding the phenotype Carecchio, Miryam
2016
22 S2 p. e77-
1 p.
artikel
369 N30 somatosensory evoked potential is negatively correlated with motor function in Parkinson's Disease Kang, Suk Yun
2016
22 S2 p. e63-
1 p.
artikel
370 Occupational exposure to organic solvents and welding fumes and risk of Parkinson's disease Kovendan, Kalimuthu
2016
22 S2 p. e30-
1 p.
artikel
371 One-year follow-up of opicapone's efficacy and safety in patients with Parkinson’s disease and motor fluctuations (BIPARK I) Ferreira, Joaquim
2016
22 S2 p. e100-
1 p.
artikel
372 ON-OFF fluctuations predict the re-emergence of fatigue in Parkinson's disease Tamburini, Tiziano
2016
22 S2 p. e42-
1 p.
artikel
373 Onset and duration of motor effects with IPX066, levodopa-carbidopa extended-release capsules: comparison with immediate-release levodopa-carbidopa and with levodopa-carbidopa+entacapone Gupta, Suneel
2016
22 S2 p. e93-
1 p.
artikel
374 Onset and duration of motor effects with IPX066, levodopa-carbidopa extended-release capsules: Comparison with immediate-release levodopa-carbidopa and with levodopa-carbidopa+entacapone Gupta, Suneel
2016
22 S2 p. e16-
1 p.
artikel
375 Opicapone improved the effect of L-DOPA on the MPTP-induced Parkinson's-like syndrome in cynomolgus monkeys Bonifacio, Maria Joao
2016
22 S2 p. e184-
1 p.
artikel
376 Opicapone improves the levodopa induced rotational behavior in 6-OHDA hemiparkinsonian rats Moura, Eduardo
2016
22 S2 p. e184-e185
nvt p.
artikel
377 Oral health-related quality of life in patients with Parkinson's disease wearing fixed partial dentures – A prospective study Pullishery, Fawaz
2016
22 S2 p. e62-e63
nvt p.
artikel
378 Oral intake of anti-hangover substance increases aldehyde dehydrogenase activity: New preventive and therapeutic potentials for oxidative neuronal injury? Bang, Chae-Young
2016
22 S2 p. e148-
1 p.
artikel
379 Oral intake of anti-hangover substance increases aldehyde dehydrogenase activity: New preventive and therapeutic potentials for oxidative neuronal injury? Bang, Chae-Young
2016
22 S2 p. e190-
1 p.
artikel
380 Origin of α-mannosidase in CSF Tasegian, Anna
2016
22 S2 p. e188-e189
nvt p.
artikel
381 Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder Lee, Si Hoon
2016
22 S2 p. e44-
1 p.
artikel
382 Otoneurological findings prevalent in hereditary ataxias Zeigelboim, Bianca Simone
2016
22 S2 p. e152-
1 p.
artikel
383 Outpatient levodopa-carbidopa intestinal gel titration in patients with advanced Parkinson's disease Rodriguez, Ramon
2016
22 S2 p. e93-
1 p.
artikel
384 Outpatient levodopa-carbidopa intestinal gel titration in patients with advanced Parkinson's disease Rodriguez, Ramon
2016
22 S2 p. e17-
1 p.
artikel
385 PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson’s disease (PD)-related pain Chaudhuri, K. Ray
2016
22 S2 p. e101-e102
nvt p.
artikel
386 PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson’s disease (PD)-related pain Chaudhuri, K. Ray
2016
22 S2 p. e85-
1 p.
artikel
387 Paradoxical effect of a high frequency stimulation protocol on temporal discrimination in dystonic patients Erro, Roberto
2016
22 S2 p. e139-
1 p.
artikel
388 Parkinson Disease non-motor profile and MAPT haplotypes Di Battista, Maria Elena
2016
22 S2 p. e39-
1 p.
artikel
389 Parkinsonism and central nervous system disease among lead exposed workers Ahn, Yeon-Soon
2016
22 S2 p. e127-
1 p.
artikel
390 Parkinsonism in acute hepatic encephalopathy: Experimental evidence in rat El Hiba, Omar
2016
22 S2 p. e126-
1 p.
artikel
391 Parkinsonism in a patient diagnosed with multiple sclerosis: a case report Khizanishvili, Nino
2016
22 S2 p. e126-
1 p.
artikel
392 Parkinson's Disease and cognitive reserve Guzzetti, Sabrina
2016
22 S2 p. e57-e58
nvt p.
artikel
393 Parkinson's disease in Senegal: epidemiologic, clinical and therapeutic aspects Gaye, Ndiaga Matar
2016
22 S2 p. e29-e30
nvt p.
artikel
394 Parkinson’s disease in Senegal: epidemiologic, clinical and therapeutic aspects Gaye, Ndiaga Matar
2016
22 S2 p. e3-
1 p.
artikel
395 Parkinson's disease or symptomatic parkinsonism? Can they be combined? Voskanyan, Anahit
2016
22 S2 p. e122-
1 p.
artikel
396 Parkinson's disease, Parkinsonism, de novo Parkinson's disease, Essential Tremor: a color vision preliminary analysis Piro, Anna
2016
22 S2 p. e42-e43
nvt p.
artikel
397 Parkinson's disease with congenital porencephalia Khanova, Mukhlisa
2016
22 S2 p. e64-
1 p.
artikel
398 Parkinson's Disease with Psychosis (PDP): Role of 5-HT2A Receptors Horowski, Reinhard
2016
22 S2 p. e92-
1 p.
artikel
399 Pathogenetic mechanisms in epileptic myoclonic hyperkinesia Kurbanov, Oybek
2016
22 S2 p. e132-
1 p.
artikel
400 Pathological gambling in Parkinson's disease patients: dopaminergic medication or personality traits fault? Brusa, Livia
2016
22 S2 p. e61-
1 p.
artikel
401 Perinatal arsenic exposure alters central dopaminergic system of rats Chandravanshi, Lalit Pratap
2016
22 S2 p. e185-
1 p.
artikel
402 Pesticide exposure and parkinsonism: A systematic review and meta-analysis Chondrogiorgi, Maria
2016
22 S2 p. e127-e128
nvt p.
artikel
403 Pharmaceutical Design in Parkinson's Disease: What Do Patients Prefer? Lefteri, Kelly
2016
22 S2 p. e15-
1 p.
artikel
404 Pharmaceutical design in Parkinson's disease: What do patients prefer? Lefteri, Kelly
2016
22 S2 p. e87-
1 p.
artikel
405 Pharmacogenetics of levodopa: An algorithm for dose prediction Altmann, Vivian
2016
22 S2 p. e89-
1 p.
artikel
406 Pharmacogenetics of levodopa: An algorithm for dose prediction Altmann, Vivian
2016
22 S2 p. e16-
1 p.
artikel
407 Pharmacokinetics of opicapone, a novel catechol-O-methyltransferase inhibitor, in the Wistar rat Gonçalves, Daniela
2016
22 S2 p. e184-
1 p.
artikel
408 Phosphorylation by okadaic acid enhances MPP+ induced hydroxyl radical generation in rat striatum Obata, Toshio
2016
22 S2 p. e182-
1 p.
artikel
409 Photo-stimulating effect of low reactive level laser can improve overactive bladder in a patient with Parkinson disease? Uchiyama, Tomoyuki
2016
22 S2 p. e113-e114
nvt p.
artikel
410 Pilates method guidelines for physical therapy in patients with Parkinson's disease Mollinedo-Cardalda, Irimia
2016
22 S2 p. e65-e66
nvt p.
artikel
411 Polymorphisms of dopamine receptor genes are associated to increased risk of visual hallucinations in Italian Parkinson's disease patients Comi, Critoforo
2016
22 S2 p. e170-
1 p.
artikel
412 Polymorphisms of genes of oxidative stress and glutamate excitotoxicity in patients with tardive dyskinesia in schizophrenia Nurmetov, Nodir
2016
22 S2 p. e175-
1 p.
artikel
413 Polysomnographic features of REM sleep behavior disorder with or without Parkinson's disease Ha, ChoongKun
2016
22 S2 p. e165-
1 p.
artikel
414 Pooled efficacy of opicapone as adjunctive therapy to levodopa in patients with Parkinson’s disease and motor fluctuations Ferreira, Joaquim
2016
22 S2 p. e101-
1 p.
artikel
415 Pooled safety and tolerability of opicapone in the treatment of Parkinson’s disease and motor fluctuations Lees, Andrew
2016
22 S2 p. e101-
1 p.
artikel
416 Positional nystagmus from BPPV in polysomnography of PD patients Valko, Yulia
2016
22 S2 p. e48-
1 p.
artikel
417 Possible involvement of Janus Kinase-Signal Transducers and Activators of Transcription (JAK/STAT) signaling pathway in vitamin E-mediated anti-depressant-like effects in a rat depression model Alrasheed, Nouf
2016
22 S2 p. e178-
1 p.
artikel
418 Post-hoc analysis of safinamide studies as add-on therapy to levodopa in mid- to late-stage fluctuating Parkinson’s disease patients Cattaneo, Carlo
2016
22 S2 p. e99-
1 p.
artikel
419 Postural instability detected by stabiloplatform examination in the patients with vascular mild cognitive impairment and Parkinson's disease patients with mild cognitive impairment Miliukhina, Irina
2016
22 S2 p. e51-
1 p.
artikel
420 Postural sensory correlates of gait freezing in Parkinson's disease Huh, Young Eun
2016
22 S2 p. e52-
1 p.
artikel
421 Posturography evaluation and balance tests as potential markers of assessment of postural disability progression in Parkinson's disease patients after DBS STN implantation Szlufik, Stanislaw
2016
22 S2 p. e51-e52
nvt p.
artikel
422 Predictive value of [123I]FP-CIT-SPECT on surgical outcome in idiopathic adult chronic hydrocephalus: A pilot study Del Gamba, Claudia
2016
22 S2 p. e127-
1 p.
artikel
423 Predictors of normal and abnormal outcome in clinical brain dopamine transporter imaging Jaakkola, Elina
2016
22 S2 p. e161-
1 p.
artikel
424 Premotor symptoms as predictors of outcome in Parkinson's Disease: A nationwide population-based and case-control study Chang, Ming-Hong
2016
22 S2 p. e37-
1 p.
artikel
425 Presenilins mutations within Moroccan cases with Alzheimer disease El Kadmiri, Nadia
2016
22 S2 p. e192-
1 p.
artikel
426 Prevalence of depression and dementia in Parkinson's disease Yunusov, Farkhod
2016
22 S2 p. e56-
1 p.
artikel
427 Progression of atrophy in brainstem structures for differentiation of progressive supranuclear palsy–parkinsonism from Parkinson’s disease Hwang, Minho
2016
22 S2 p. e121-
1 p.
artikel
428 Progression of Parkinson's disease during the 5 year follow up Petrovic, Mirjana
2016
22 S2 p. e35-
1 p.
artikel
429 Progressive axonal degeneration of the striatonigral dopaminergic neurons in calcium-independent phospholipase A2β-knockout mice Beck, Goichi
2016
22 S2 p. e179-
1 p.
artikel
430 Protective effects of superoxide dismutation activity in genetic models of Parkinson’s disease Biosa, Alice
2016
22 S2 p. e88-
1 p.
artikel
431 Pulmonary function and clinical characteristics of Parkinson's disease Cheon, Sang-Myung
2016
22 S2 p. e47-
1 p.
artikel
432 Putaminal diffusivity changes correlates with motor progression in Parkinson's disease on 6-year follow-up Chan, L.L.
2016
22 S2 p. e158-e159
nvt p.
artikel
433 Putaminal diffusivity changes correlates with motor progression in Parkinson's disease on 6-year follow-up Chan, L.L.
2016
22 S2 p. e82-e83
nvt p.
artikel
434 Quality of life in patients with Parkinson's Disease in Uzbekistan Tolibova, Navruza
2016
22 S2 p. e38-
1 p.
artikel
435 Quality of life measured by PDQ39 and SEIQoL during anti-stress training for Parkinson's disease (PD) patients Nowak, Karolina
2016
22 S2 p. e13-
1 p.
artikel
436 Quality of life measured by PDQ39 and SEIQoL during anti-stress training for Parkinson's disease (PD) patients Nowak, Karolina
2016
22 S2 p. e71-
1 p.
artikel
437 Randomized double-blind, placebo-controlled multi-center trial for determining efficacy of molecular hydrogen water for Parkinson’s disease, Baseline characteristics Yoritaka, Asako
2016
22 S2 p. e88-e89
nvt p.
artikel
438 Recognition of life-long curiosity in Parkinson Disease treatment developments Riederer, Peter
2016
22 S2 p. e64-
1 p.
artikel
439 Recognition of life-long curiosity in Parkinson disease treatment developments Riederer, Peter
2016
22 S2 p. e27-
1 p.
artikel
440 Reconsidering diagnosis and prevalence of Neuropathy in PD Rubino, Alfonso
2016
22 S2 p. e63-
1 p.
artikel
441 Reflex saccades evaluation can estimate long-term symptom progression in DBS STN vs only medically treated Parkinson's disease patients Szlufik, Stanislaw
2016
22 S2 p. e23-
1 p.
artikel
442 Reflex saccades evaluation can estimate long-term symptom progression in DBS STN vs only medically treated Parkinson’s disease patients Szlufik, Stanislaw
2016
22 S2 p. e109-
1 p.
artikel
443 Regional brain atrophy and cognitive impairment of pure akinesia with gait freezing Hong, Jin Yong
2016
22 S2 p. e121-
1 p.
artikel
444 Relationship between Stay-at-home Patients' Understanding of Information regarding their Parkinson's Disease and the Burden of Spouse Caregivers Takamoto, Hisashi
2016
22 S2 p. e11-
1 p.
artikel
445 Relationship between stay-at-home patients' understanding of information regarding their Parkinson's Disease and the burden of spouse caregivers Takamoto, Hisashi
2016
22 S2 p. e65-
1 p.
artikel
446 Relationship S100 protein levels in blood plasma with a frequency of occurrence of cardiovascular complications in Parkinson's disease Juraev, Mirzo
2016
22 S2 p. e46-
1 p.
artikel
447 REM Sleep Behavior Disorder (RBD) as a predictor of development of daytime hypersomnia and nocturia in Parkinson's disease (PD) Nodel, Marina
2016
22 S2 p. e40-
1 p.
artikel
448 REM sleep behaviour disorder and cognitive functions in Parkinson's disease Lyashenko, Elena
2016
22 S2 p. e39-e40
nvt p.
artikel
449 Research on neuropsychiatric symptoms in patients with essential tremor and Parkinson’s disease in Latvian population Smeltere, Ligita
2016
22 S2 p. e130-
1 p.
artikel
450 Restoration of tensegrity equilibrium can lead to beneficial modification of Parkinson Disease's motor symptoms Vucolova, Ludmila
2016
22 S2 p. e66-
1 p.
artikel
451 Restoration of Tensegrity Equilibrium Can Lead to Beneficial Modification of Parkinson Disease's Motor Symptoms Vucolova, Ludmila
2016
22 S2 p. e11-
1 p.
artikel
452 Reversible hemichorea-hemiballism associated with post-thrombolysis reperfusion Kim, Hee Jin
2016
22 S2 p. e134-
1 p.
artikel
453 Review of interventions to reduce hospitalisation in Parkinson's disease Muzerengi, Sharon
2016
22 S2 p. e64-
1 p.
artikel
454 Risk of cancer among patients with Parkinson disease Naghavi-Behzad, Mohammad
2016
22 S2 p. e34-
1 p.
artikel
455 Role of dopaminergic receptors and post synaptic signaling in arsenic induced neurotoxicity: Ameliorative effect of curcumin Srivastava, Pranay
2016
22 S2 p. e185-
1 p.
artikel
456 Role of dopaminergic receptors and post synaptic signaling in arsenic induced neurotoxicity: Ameliorative effect of curcumin Srivastava, Pranay
2016
22 S2 p. e147-
1 p.
artikel
457 Role of striatal projection neurons in the generation of L-DOPA-induced dyskinesia Alcacer, Cristina
2016
22 S2 p. e90-
1 p.
artikel
458 Rotigotine efficacy on sleep disturbances in Parkinson’s disease patients: Evidence from a polysomnographic study Liguori, Claudio
2016
22 S2 p. e102-
1 p.
artikel
459 Rotigotine efficacy on sleep disturbances in Parkinson's disease patients: Evidence from a polysomnographic study Liguori, Claudio
2016
22 S2 p. e21-
1 p.
artikel
460 Safety of sublingual apomorphine (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease Agro, Albert
2016
22 S2 p. e104-
1 p.
artikel
461 Safinamide and glutamate release: New insights Melloni, Elsa
2016
22 S2 p. e177-
1 p.
artikel
462 Safinamide differentially modulates glutamate release in the basal ganglia nuclei Morari, Michele
2016
22 S2 p. e176-e177
nvt p.
artikel
463 Screening of spontaneous genomic alterations and p53 gene polymorphism in new onset of Parkinson disease Ramalingam, Jayalakshmi
2016
22 S2 p. e171-
1 p.
artikel
464 Semantic and phonemic verbal fluency in patients with Parkinson's disease (PD) Roesch, Anne Dorothée
2016
22 S2 p. e54-e55
nvt p.
artikel
465 Semantic and phonemic verbal fluency in patients with Parkinson's disease (PD) Roesch, Anne Dorothée
2016
22 S2 p. e7-
1 p.
artikel
466 Sensory attenuation and Parkinson's disease: a new pathophysiological framework of bradykinesia Macerollo, Antonella
2016
22 S2 p. e62-
1 p.
artikel
467 Sensory attenuation and Parkinson's disease: A new pathophysiological framework of bradykinesia Macerollo, Antonella
2016
22 S2 p. e9-
1 p.
artikel
468 Sex differences in Parkinson's disease Fiszer, Urszula
2016
22 S2 p. e29-
1 p.
artikel
469 Short and long term effect of cognitive rehabilitation in mild cognitive impairment subtypes in Parkinson's disease Diez-Cirarda, Maria
2016
22 S2 p. e74-
1 p.
artikel
470 Sleep and mood predict quality of life change in Parkinson's disease: a longitudinal study Prakash, Kumar M.
2016
22 S2 p. e39-
1 p.
artikel
471 Sleep and motor symptoms in Parkinson's Disease with REM sleep behavior disorder: A preliminary study Park, Kee Hyung
2016
22 S2 p. e40-
1 p.
artikel
472 Sleep architecture observed in the patients with SCA 10 London, Ester
2016
22 S2 p. e150-e151
nvt p.
artikel
473 Speech disorders and Parkinson’s disease Pettorino, Massimo
2016
22 S2 p. e4-
1 p.
artikel
474 Speech disorders and Parkinson's disease Pettorino, Massimo
2016
22 S2 p. e48-
1 p.
artikel
475 Spike shape analysis of electromyography for parkinsonian tremor evaluation Marusiak, Jaroslaw
2016
22 S2 p. e129-
1 p.
artikel
476 Sporadic progressive ataxia with palatal tremor Agarwal, Shashank
2016
22 S2 p. e154-e155
nvt p.
artikel
477 Spreading depression susceptibility is reduced in Parkinson rat model Lotfinia, Mahmoud
2016
22 S2 p. e180-
1 p.
artikel
478 Stress Reduction Training in PD Patients – Influence on neuropsychiatric symptoms? Meyer, Antonia
2016
22 S2 p. e71-
1 p.
artikel
479 Stress Reduction Training in PD Patients – Influence on neuropsychiatric symptoms? Meyer, Antonia
2016
22 S2 p. e12-
1 p.
artikel
480 Structural analysis of alpha-synuclein oligomers via antibody fingerprinting Nilsson, Lina
2016
22 S2 p. e189-
1 p.
artikel
481 Structural and functional myocardial abnormalities in patients with Parkinson's disease compared with control group: an echocardiographic study Gonzalez-Martinez, Alicia
2016
22 S2 p. e45-e46
nvt p.
artikel
482 Structural changes in basal ganglia-thalamocortical circuits in Parkinson's disease with cognitive impairment Son, Andre
2016
22 S2 p. e157-e158
nvt p.
artikel
483 Studying pain-related manifestations in an MPTP-induced rat model of Parkinson's disease Padurariu, Manuela
2016
22 S2 p. e182-
1 p.
artikel
484 Subthalamic deep brain stimulation in Parkinson’s disease: Does the therapeutic range remain the same in the absence of clinical intraoperative testing? Zouitina, Yassine
2016
22 S2 p. e107-
1 p.
artikel
485 Suicidal ideation in Parkinson's disease Dumitru, Maria Magdalena
2016
22 S2 p. e56-
1 p.
artikel
486 Symptomatic and biochemical assessments using microdialysis method of an antidyskinetic compound in a L-DOPA induced dyskinesias rat model Robelet, Sandra
2016
22 S2 p. e181-
1 p.
artikel
487 Symptomatic efficacy of rasagiline in early PD: A meta-analysis Hauser, Robert A.
2016
22 S2 p. e91-
1 p.
artikel
488 Synapsin III alterations in Parkinson's disease Bellucci, Arianna
2016
22 S2 p. e189-
1 p.
artikel
489 Synaptic homeostasis in Parkinson's disease: An high-density EEG study in different stage of the disease Trendafilov, Viktor
2016
22 S2 p. e142-
1 p.
artikel
490 Synaptic homeostasis in Parkinson's disease: An high-density EEG study in different stage of the disease Trendafilov, Viktor
2016
22 S2 p. e163-
1 p.
artikel
491 Systems biology analysis of the proteomic alterations in Parkinson's disease: Common and disease-specific pathways Alberio, Tiziana
2016
22 S2 p. e173-e174
nvt p.
artikel
492 Tardive dyskinesia after long-term treatment with topical prostoglandin F2α analog (latanoprost) Bulut, Burcu
2016
22 S2 p. e134-e135
nvt p.
artikel
493 Telemedicine facilitates efficient and safe home titration of levodopa/carbidopa intestinal gel (LCIG) in patients with advanced Parkinson's disease Willows, Thomas
2016
22 S2 p. e95-
1 p.
artikel
494 The ability of autonomic function tests to detect the possible deterioration of autonomic system in PD patients – preliminary results Strasz, Anna
2016
22 S2 p. e43-e44
nvt p.
artikel
495 The association with cognitive function in Lewy body disease: The study of serum biomarkers Nakashita, Satoko
2016
22 S2 p. e116-
1 p.
artikel
496 Theatre is a valid complementary therapeutic intervention for emotional rehabilitation in Parkinson's disease patients Mirabella, Giovanni
2016
22 S2 p. e14-
1 p.
artikel
497 Theatre is a valid complementary therapeutic intervention for emotional rehabilitation in Parkinson's disease patients Mirabella, Giovanni
2016
22 S2 p. e74-e75
nvt p.
artikel
498 The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation Faggiani, Emilie
2016
22 S2 p. e111-
1 p.
artikel
499 The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation Faggiani, Emilie
2016
22 S2 p. e24-
1 p.
artikel
500 The control of quiet stance in persons with Parkinson's disease Rigoldi, Chiara
2016
22 S2 p. e68-
1 p.
artikel
501 The distribution and progression pattern of adult onset cerebellar ataxias: Hospital based study Kim, Ji Sun
2016
22 S2 p. e149-
1 p.
artikel
502 The 2D-Medial Temporal lobe Atrophy (2D-MTA) correlates with memory in Parkinson's disease Avellon, Tania Alvarez
2016
22 S2 p. e159-
1 p.
artikel
503 The effectiveness of amantadine and dopamine in the treatment of Guillain-Barre syndrome Tadjenov, Marat
2016
22 S2 p. e90-e91
nvt p.
artikel
504 The effect of bilateral sub-thalamic nucleus deep brain stimulation (STN-DBS) on prosody of speech of Parkinson's disease Majdinasab, Fatemeh
2016
22 S2 p. e22-e23
nvt p.
artikel
505 The effect of bilateral sub-thalamic nucleus deep brain stimulation (STN-DBS) on prosody of speech of Parkinson’s disease Majdinasab, Fatemeh
2016
22 S2 p. e106-
1 p.
artikel
506 The effect of deep brain stimulation of subthalamic nucleus on cognitive functions in Parkinson's disease – Pilot study Potasz-Kulikowska, Katarzyna
2016
22 S2 p. e106-e107
nvt p.
artikel
507 The effect of subthalamic deep brain stimulation on ghrelin levels in Parkinson’s disease Chrobak, Adrian
2016
22 S2 p. e107-
1 p.
artikel
508 The effects of sublingual apomorphine (APL-130277) by disease severity on the acute reversal of OFF episodes in Parkinson’s disease patients Dubow, Jordan
2016
22 S2 p. e103-
1 p.
artikel
509 The First Parkinson's Disease Pain Questionnaire (King's PD Pain Quest) – an interim analysis of a multicentre study of the patient's perspective Rizos, Alexandra
2016
22 S2 p. e41-
1 p.
artikel
510 The hippocampal serotonin system is related with the antidepressant effect of sertraline, venlafaxine, nortriptyline and L-tryptophan in the 6-OHDA-lesioned rats Vital, Maria
2016
22 S2 p. e180-
1 p.
artikel
511 The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease Kovács, Norbert
2016
22 S2 p. e94-
1 p.
artikel
512 The impact of microelectrode recording on selecting the most optimal trajectories for electrode implantation Nagy, Máté
2016
22 S2 p. e108-
1 p.
artikel
513 The impact of microelectrode recording on selecting the most optimal trajectories for electrode implantation Nagy, Máté
2016
22 S2 p. e23-
1 p.
artikel
514 The impact of STN DBS on kinetic tremor in Parkinson's disease patients Szlufik, Stanislaw
2016
22 S2 p. e24-
1 p.
artikel
515 The impact of STN DBS on kinetic tremor in Parkinson’s disease patients Szlufik, Stanislaw
2016
22 S2 p. e109-e110
nvt p.
artikel
516 The importance of Ishihara Testing in early diagnosing of Parkinson disease Mirdedaev, Sanjarbek
2016
22 S2 p. e43-
1 p.
artikel
517 The importance of the vestibular evaluation in the body balance prognosis and therapy in spinocerebellar ataxia Zeigelboim, Bianca Simone
2016
22 S2 p. e152-
1 p.
artikel
518 The 1-metylxantine affinity for A2A adenosine receptors is similar to caffeine, theobromine, theophylline and adenosine. The importance of xanthine core. Jimenez-Botello, Luis Clemente
2016
22 S2 p. e100-e101
nvt p.
artikel
519 The MIBG scintigraphy and DAT SPECT contribute to the diagnosis of PD and other related disorders, and evaluations of the course and stage of PD Tada, Satoshi
2016
22 S2 p. e162-
1 p.
artikel
520 The MIBG scintigraphy and DAT SPECT contribute to the diagnosis of PD and other related disorders, and evaluations of the course and stage of PD Tada, Satoshi
2016
22 S2 p. e83-
1 p.
artikel
521 The mutation causing the motor and behavioral disorders in white mice Turgunkhujaev, Oybek
2016
22 S2 p. e178-e179
nvt p.
artikel
522 Theory of the mind in subjects with Parkinson's disease: A case-control study Arciniega-Martinez, Genny Giselle
2016
22 S2 p. e58-
1 p.
artikel
523 The painful dimension of Parkinson's disease – Relation between pain, depression and sleep Nicolae, H.
2016
22 S2 p. e40-e41
nvt p.
artikel
524 The plasma level of alpha-synuclein in lysosomal storage diseases Muinjonov, Bakhrom
2016
22 S2 p. e116-e117
nvt p.
artikel
525 The potential of cognitive-behavioral intervention for anxiety in Parkinson's disease Reynolds, Gretchen O.
2016
22 S2 p. e73-e74
nvt p.
artikel
526 The protective effect of curcumin on dopaminergic system after chronic aluminium intoxication: Possible link with Parkinson's disease Laabdar, Wafaa
2016
22 S2 p. e188-
1 p.
artikel
527 Therapeutic assessment of Botulinum toxin in the treatment of hemifacial spasm Teive, Helio
2016
22 S2 p. e138-
1 p.
artikel
528 The relationship between serum and cerebrospinal fluid inflammatory biomarkers in Parkinson's disease Miliukhina, Irina
2016
22 S2 p. e31-e32
nvt p.
artikel
529 The rise, the fall and the revival of hyperglycemic hemichorea Lee, Dokyung
2016
22 S2 p. e134-
1 p.
artikel
530 The role and significance of neuron specific protein S100B in extrapyramidal disorders Juraev, Mirzo
2016
22 S2 p. e155-
1 p.
artikel
531 The role of the motor cortex in essential tremor Sharifi, Sarvi
2016
22 S2 p. e128-
1 p.
artikel
532 The study of the prevalence of Parkinson disease Karbozova, Kunduz
2016
22 S2 p. e29-
1 p.
artikel
533 The three-dimensional motion analysis system as an useful tool in evaluation of gait disorders in Parkinson’s disease patients treated with DBS STN Szlufik, Stanislaw
2016
22 S2 p. e110-
1 p.
artikel
534 The worse is the clinical status of the patient with Parkinson, the higher is the stride length percentage of improvement after Automated Mechanical Peripheral Stimulation Kleiner, Ana
2016
22 S2 p. e69-e70
nvt p.
artikel
535 The worse is the clinical status of the patient with Parkinson, the higher is the stride length percentage of improvement after Automated Mechanical Peripheral Stimulation. Kleiner, Ana
2016
22 S2 p. e12-
1 p.
artikel
536 Three new techniques for improving DBS therapy: What are we waiting for? Bour, Lo
2016
22 S2 p. e108-e109
nvt p.
artikel
537 Timed up and Go and its application in older adults with Parkinson's disease. Systematic review Mollinedo-Cardalda, Irimia
2016
22 S2 p. e53-
1 p.
artikel
538 Tobacco increases dystonia risk but may ameliorate symptoms Hellberg, Clara
2016
22 S2 p. e78-
1 p.
artikel
539 Tobacco increases dystonia risk but may ameliorate symptoms Hellberg, Clara
2016
22 S2 p. e137-e138
nvt p.
artikel
540 Transcranial B-mode sonography in Parkinson's disease and parkinsonism: Our experience on 403 patients Ravagnani, Mara
2016
22 S2 p. e155-
1 p.
artikel
541 Transcranial direct current stimulation in the treatment of essential tremor Yilmaz, Nesrin Helvaci
2016
22 S2 p. e130-
1 p.
artikel
542 Transcranial magnetic stimulation for rehabilitation of axial symptoms in Parkinson’s disease Biagioni, Milton
2016
22 S2 p. e114-
1 p.
artikel
543 Treatment and diagnosis with the use of neuropsychological scale in patients with subcortical parkinsonian dementia Sokhibnazarov, Nodirjon
2016
22 S2 p. e74-
1 p.
artikel
544 Treatment with l-dopa normalize learning as measured with CVLT-2 in drug naive patients with Parkinson’s disease Sari, Hilde Therese Johansen
2016
22 S2 p. e89-e90
nvt p.
artikel
545 Treatment with l-dopa normalize learning as measured with CVLT-2 in drug naive patients with Parkinson’s disease Johansen Sari, Hilde Therese
2016
22 S2 p. e16-
1 p.
artikel
546 Two new SCL20A2 mutations identified in two southern Italy families with primary familial brain calcification Scannapieco, Sara
2016
22 S2 p. e174-
1 p.
artikel
547 Typical atypical or atypical atypical Parkinsonism? Hirschbichler, Stephanie T.
2016
22 S2 p. e117-
1 p.
artikel
548 Understanding the differential regulation of GBA and GBAP1 expression Rimoldi, Valeria
2016
22 S2 p. e189-
1 p.
artikel
549 Understanding the differential regulation of GBA and GBAP1 expression Rimoldi, Valeria
2016
22 S2 p. e86-
1 p.
artikel
550 Unilateral deep brain stimulation of subthalamic nuclei does not affect reactive inhibition in Parkinson's patients Mirabella, Giovanni
2016
22 S2 p. e24-e25
nvt p.
artikel
551 Unilateral deep brain stimulation of subthalamic nuclei does not affect reactive inhibition in Parkinson’s patients Mirabella, Giovanni
2016
22 S2 p. e111-
1 p.
artikel
552 Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's disease Michel, Anne
2016
22 S2 p. e181-
1 p.
artikel
553 Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson’s disease Michel, Anne
2016
22 S2 p. e86-
1 p.
artikel
554 Unrevealing the diagnoses of a sample of cases with hard-to-classify tremor and normal DaT-SPECT Menendez-Gonzalez, Manuel
2016
22 S2 p. e129-
1 p.
artikel
555 Updated long-term safety from ongoing phase 3 trials of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease Rodriguez, Ramon
2016
22 S2 p. e97-
1 p.
artikel
556 Updated long-term safety from ongoing phase 3 trials of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease Rodriguez, Ramon
2016
22 S2 p. e84-
1 p.
artikel
557 Urinary markers of oxidative stress in early Parkinson's disease Calzetti, Stefano
2016
22 S2 p. e31-
1 p.
artikel
558 Usefulness of Parkinson's KinetiGraph in a Parkinson's disease clinic – Survey of 82 patients Klingelhoefer, Lisa
2016
22 S2 p. e37-
1 p.
artikel
559 Usefulness of the well being map for the follow-up of Parkinson's disease patients Schuller, Béatrice
2016
22 S2 p. e65-
1 p.
artikel
560 Use of the drug choline alfostserat (Gliatilin) in combined treatment of vascular parkinsonism Kurbanov, Oybek
2016
22 S2 p. e124-
1 p.
artikel
561 Use of three-dimensional gait analysis to assess the effectiveness of conventional rehabilitation protocols in people with Parkinson's disease Pau, Massimiliano
2016
22 S2 p. e69-
1 p.
artikel
562 Use of three-dimensional gait analysis to assess the effectiveness of conventional rehabilitation protocols in people with Parkinson's disease Pau, Massimiliano
2016
22 S2 p. e12-
1 p.
artikel
563 Using the “StartReact” paradigm to investigate postural instability in Parkinson's Disease Tan, Joy
2016
22 S2 p. e52-e53
nvt p.
artikel
564 Validation of the Italian non motor symptoms questionnaire and non motor symptoms scale for Parkinson's disease Cova, Ilaria
2016
22 S2 p. e38-e39
nvt p.
artikel
565 Vanishing white matter disease and juvenile lateral sclerosis type 4: Possibly a novel genetic and clinical overlap Good, Jean-Marc
2016
22 S2 p. e174-e175
nvt p.
artikel
566 Vascular parkinsonism as a common manifestation of second stage of CADASIL syndrome Muinjonov, Bakhrom
2016
22 S2 p. e123-
1 p.
artikel
567 Vascular Parkinsonism as a common manifestation of second stage of CADASIL syndrome Muinjonov, Bakhrom
2016
22 S2 p. e76-
1 p.
artikel
568 Vascular risk factors and depressive symptoms in Parkinson's disease dementia Park, Moon Ho
2016
22 S2 p. e57-
1 p.
artikel
569 Vegetative nervous system status according to cardiointervalogram data of ethnic Kyrgyz people with Parkinson disease Chekeeva, Nargiza
2016
22 S2 p. e45-
1 p.
artikel
570 Visual Hallucination Inventory (VHI) and NMS Questionnaire (NMSQ) in identification and characterisation of Visual Hallucinations (VH) in elderly patients with Parkinson's disease (PD) Gangadharan, Sanjay
2016
22 S2 p. e60-
1 p.
artikel
571 Visuospatial, visuoconstructive and visuoperceptive functioning in patients with Parkinson's disease Rodriguez-Violante, Mayela
2016
22 S2 p. e42-
1 p.
artikel
572 Volumetry of the olfactory bulbs and tracts in the differential diagnosis of Parkinson's disease from parkinsonisms Menendez-Gonzalez, Manuel
2016
22 S2 p. e157-
1 p.
artikel
573 Weight gain after subthalamic nucleus deep brain stimulation in PD: The role of electrodes position, hormonal setting and clinical outcome Fichera, Mario
2016
22 S2 p. e110-
1 p.
artikel
574 What can go wrong? Sexual dysfunction in Parkinson's Disease Serbanoiu, Irina
2016
22 S2 p. e47-
1 p.
artikel
575 Whether the Parkinson's disease develops in patients with chronic cerebral ischemia? Izyumov, Daniyar
2016
22 S2 p. e122-
1 p.
artikel
576 White matter changes associated with cognitive impairment in Parkinson's disease Chondrogiorgi, Maria
2016
22 S2 p. e158-
1 p.
artikel
577 Wilson disease: Acute dystonia during treatment with SSRI or SNRI Wictor, Lars
2016
22 S2 p. e78-e79
nvt p.
artikel
578 Wilson disease: Acute dystonia during treatment with SSRI or SNRI Wictor, Lars
2016
22 S2 p. e140-e141
nvt p.
artikel
579 Zero non-motor symptoms in a martial arts expert Jaffe, Linda
2016
22 S2 p. e75-
1 p.
artikel
580 Zolpidem in movement disorder after cardiac arrest Teive, Helio
2016
22 S2 p. e139-
1 p.
artikel
                             580 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland